Asthma Spacers Global Market Report 2024

The asthma spacers market size has grown strongly in recent years. It will grow from $1.77 billion in 2023 to $1.88 billion in 2024 at a compound annual growth rate (CAGR) of 6.3%. The expansion observed during the historical period can be attributed to several factors, including the increasing prevalence of asthma, improved diagnosis and awareness of the condition, regulatory approvals and guidelines governing asthma management, the development of healthcare infrastructure, and advancements in insurance and reimbursement policies.

The asthma spacers market size is expected to see strong growth in the next few years. It will grow to $2.42 billion in 2028 at a compound annual growth rate (CAGR) of 6.4%. The anticipated growth in the forecast period can be attributed to several factors, including the rising pediatric and geriatric populations, a heightened focus on preventive healthcare, advancements in telemedicine, the emergence of new markets, patient education and training programs, collaborations and partnerships within the healthcare industry, and the adoption of personalized medicine approaches. Key trends expected in the forecast period encompass the widespread adoption of smart inhalers, a heightened focus on pediatric asthma management, increased demand for portable asthma management devices, the integration of telehealth services, a surge in research and development investments, and the development of personalized management solutions for asthma patients.

The anticipated increase in air pollution is set to drive the growth of the asthma spacer market in the coming years. Air pollution, comprising harmful substances in the atmosphere detrimental to human health and the environment, poses a significant environmental and public health challenge attributed to natural and human activities. Asthma spacers serve as a preventative measure during periods of heightened air pollution by reducing the intake of pollutants into the airways when using inhalers, thereby lowering the risk of exacerbating asthma symptoms due to airborne irritants. For example, data from the International Energy Agency (IEA) revealed a 1.1% increase in global energy-related carbon dioxide (CO2) emissions in 2023, amounting to 410 million metric tons (Mt CO2) compared to 321 million metric tons in 2022. This surge is reaching a record high of over 37.4 metric tons in 2023, up from 36.8 billion metric tons in 2022. The escalating air pollution levels will consequently fuel the demand for asthma spacers.

Key players in the asthma spacer market are directing their efforts towards integrating smart technologies with connected metered-dose inhaler (MDI) devices to enhance patient adherence and optimize treatment outcomes. Connected MDI devices leverage digital technology to monitor usage, track adherence, and provide data to patients and healthcare providers for improved respiratory disease management. For instance, in February 2022, Aptar Pharma, a US-based pharmaceutical manufacturing company, introduced the HeroTracker Sense, a smart connected healthcare device designed for tracking and monitoring medication usage in respiratory diseases such as asthma. This innovative solution enables patients to accurately measure and record their inhaler doses, offering valuable insights to healthcare professionals for personalized treatment strategies. This shift towards personalized and technology-driven solutions in the asthma spacer market aims to enhance patient outcomes and overall healthcare efficiency.

In January 2022, ICU Medical Inc., a US-based medical equipment manufacturing company, completed the acquisition of Smiths Medical International Limited for approximately $2.7 billion. The acquisition aims to broaden its portfolio and global presence in the healthcare sector, leveraging the expertise and resources of both entities. Smith’s Medical International Limited, a UK-based medical technology company, specializes in providing innovative solutions for healthcare professionals and patients, including asthma spacers.

Major companies operating in the asthma spacers market are Merck & Co. Inc., AstraZeneca Plc., Novartis AG, GlaxoSmithKline plc, Koninklijke Philips NV, Teva Pharmaceutical Industries Ltd, Mylan NV, Boehringer Ingelheim International GmbH, Smiths Medical Inc, AptarGroup Inc., Cipla Limited, Teleflex Incorporated, Lupin Limited, Mundipharma International Limited, SunMed Holdings LLC, Drive DeVilbiss Healthcare, Trudell Medical International, Bird HealthCare Pty Ltd, Vyaire Medical Inc, Omron Healthcare Inc, PARI GmbH, Vitalograph, Monaghan Medical Corporation, Medical Developments International Ltd, Clement Clarke International Ltd, Instrumentation Industries Inc.

North America was the largest region in the asthma spacers market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the asthma spacers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the asthma spacers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Asthma spacers are essential medical devices used alongside metered-dose inhalers (MDIs) to optimize the delivery of aerosolized medication into the lungs. These devices, commonly referred to as holding chambers, serve to enhance the efficiency of medication delivery to the lungs and are available in various shapes and sizes.

The primary product types of asthma spacers include aerochamber, optichamber, volumatic, inspirease, and others. Aerochamber, for instance, aids in the effective delivery of medication from an inhaler to the lungs by offering a holding chamber for the aerosol medication, thereby ensuring a greater portion of the medication reaches its target destination. These products are distributed through various channels such as e-commerce platforms, retail pharmacies, hospital pharmacies, among others, and are utilized for preventive, rescue, or combined use applications. End-users encompass homecare settings, hospitals, clinics, and other medical facilities.

The asthma spacers market research report is one of a series of new reports that provides asthma spacers market statistics, including asthma spacers industry global market size, regional shares, competitors with an asthma spacers market share, detailed asthma spacers market segments, market trends and opportunities, and any further data you may need to thrive in the asthma spacers industry. This asthma spacers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The asthma spacers market consists of sales of simple tube spacers, and valved holding chambers (VHCs). Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.